FFCP PHASE1:Mm9::chr15:74686669..74686674,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=13072|HGNC=|MCL_coexpression_id=146|UniProt=P15539,G3UWE4|association_with_transcript=73bp_to_ENSMUST00000023253,ENSMUST00000167634,NM_009991,uc007wgf.2_5end|description=CAGE_peak_2_at_Cyp11b2_5end|id=chr15:74686669..74686674,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002369!7.57e-42!7;UBERON:0006858!7.57e-42!7;UBERON:0002342!2.62e-29!10;UBERON:0005062!2.62e-29!10;UBERON:0003064!6.29e-21!14;UBERON:0005157!8.70e-11!27|ontology_enrichment_uberon_v019_2=UBERON:0002369,2.40e-74,7;UBERON:0006858,2.40e-74,7;UBERON:0003064,1.49e-37,14;UBERON:0005256,4.78e-12,45;UBERON:0005172,4.27e-11,49;UBERON:0005173,4.27e-11,49;UBERON:0002417,4.27e-11,49;UBERON:0000916,4.27e-11,49;UBERON:0002368,3.96e-09,60;UBERON:0003104,5.52e-09,61;UBERON:0009142,5.52e-09,61;UBERON:0002530,1.88e-08,65;UBERON:0009569,2.50e-08,66;UBERON:0000949,1.17e-07,72;UBERON:0005177,5.28e-07,79|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68.1349418307546,0,6.08930956624282,18.4492397804847,26.8286300183668,11.170927177892,15.0799909595611,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162886959353576,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0762068066549998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0574354689556133,0,0.115884325944855,0,0,0,0,0,0,0,0,0.0846146078916765,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p2@Cyp11b2}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:13072 | |||
|HGNC= | |||
|MCL_coexpression_id=146 | |||
|TSSclassifier=NA | |||
|UniProt=uniprot:P15539,uniprot:G3UWE4 | |||
|association_with_transcript=73bp_to_ENSMUST00000023253,ENSMUST00000167634,NM_009991,uc007wgf.2_5end | |||
|cluster_id=chr15:74686669..74686674,- | |||
|description=CAGE_peak_2_at_Cyp11b2_5end | |||
|id=chr15:74686669..74686674,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002369!7.57e-42!7;UBERON:0006858!7.57e-42!7;UBERON:0002342!2.62e-29!10;UBERON:0005062!2.62e-29!10;UBERON:0003064!6.29e-21!14;UBERON:0005157!8.70e-11!27 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002369,2.40e-74,7;UBERON:0006858,2.40e-74,7;UBERON:0003064,1.49e-37,14;UBERON:0005256,4.78e-12,45;UBERON:0005172,4.27e-11,49;UBERON:0005173,4.27e-11,49;UBERON:0002417,4.27e-11,49;UBERON:0000916,4.27e-11,49;UBERON:0002368,3.96e-09,60;UBERON:0003104,5.52e-09,61;UBERON:0009142,5.52e-09,61;UBERON:0002530,1.88e-08,65;UBERON:0009569,2.50e-08,66;UBERON:0000949,1.17e-07,72;UBERON:0005177,5.28e-07,79 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68.1349418307546,0,6.08930956624282,18.4492397804847,26.8286300183668,11.170927177892,15.0799909595611,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162886959353576,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0762068066549998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0574354689556133,0,0.115884325944855,0,0,0,0,0,0,0,0,0.0846146078916765,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p2@Cyp11b2 | |||
}} |
Revision as of 11:13, 5 August 2015
Short description: | p2@Cyp11b2 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_2_at_Cyp11b2_5end |
Coexpression cluster: | MCL_coexpression_mm9:146 |
Association with transcript: | 73bp_to_ENSMUST00000023253, ENSMUST00000167634, NM_009991, uc007wgf.2_5end |
EntrezGene: | 13072 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
adrenal gland | 2.40e-74 | 7 |
adrenal/interrenal gland | 2.40e-74 | 7 |
intermediate mesoderm | 1.49e-37 | 14 |
trunk mesenchyme | 4.78e-12 | 45 |
abdomen element | 4.27e-11 | 49 |
abdominal segment element | 4.27e-11 | 49 |
abdominal segment of trunk | 4.27e-11 | 49 |
abdomen | 4.27e-11 | 49 |
endocrine gland | 3.96e-09 | 60 |
mesenchyme | 5.52e-09 | 61 |
entire embryonic mesenchyme | 5.52e-09 | 61 |
gland | 1.88e-08 | 65 |
subdivision of trunk | 2.50e-08 | 66 |
endocrine system | 1.17e-07 | 72 |
trunk region element | 5.28e-07 | 79 |